- CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
- CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS
- CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In China
- CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA
Key statistics
On Tuesday, CASI Pharmaceuticals Inc (CASI:NAQ) closed at 2.51, 35.68% above the 52 week low of 1.85 set on Jun 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.41 |
---|---|
High | 2.51 |
Low | 2.36 |
Bid | 2.42 |
Offer | 2.52 |
Previous close | 2.43 |
Average volume | 46.63k |
---|---|
Shares outstanding | 13.40m |
Free float | 7.04m |
P/E (TTM) | -- |
Market cap | 32.57m USD |
EPS (TTM) | -2.02 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 21:00 BST.
More ▼